Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000780 · ClinicalTrials.gov registry record

A "Pre-Enrollment" Protocol for HIV-Infected Adolescents

A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
250
Enrollment target
20
Study locations

NCT00000780 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 250 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000780, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
250 participants
Enrollment target
20
Study locations

Study Summary

PRIMARY: To identify, characterize, and co-enroll HIV-infected adolescents into existing and future ACTG (or other NIH-sponsored) HIV treatment protocols through the systematic and recurrent assessment of eligibility. To assess the ability of adolescents enrolled in ACTG 220 to adhere to ACTG (or other NIH-sponsored) HIV treatment protocols; and to define factors that influence the adolescent's ability to enter or adhere to study protocols. SECONDARY: To describe the nature, stage, and progression of HIV infection in adolescents. Little is known about HIV-infected adolescents as a group and, as a result, small numbers of them are currently enrolled in ACTG drug studies. Creative approaches are needed to encourage enrollment of HIV-infected adolescents whose socio-demographic profile has made access to NIH-sponsored research unlikely.

Conditions Studied

HIV Infections

Study Locations (20)

California

  • Long Beach Memorial (Pediatric) - Long Beach
  • Children's Hosp of Los Angeles/UCLA Med Ctr - Los Angeles
  • Children's Hosp of Los Angeles - Los Angeles
  • Los Angeles County - USC Med Ctr - Los Angeles
  • UCLA Med Ctr / Pediatric - Los Angeles
  • Children's Hosp of Oakland - Oakland
  • UCSF / Moffitt Hosp - Pediatric - San Francisco

District of Columbia

  • Georgetown Univ Med Ctr - Washington D.C.
  • Children's Hosp of Washington DC - Washington D.C.
  • George Washington Univ / Hershey Med Ctr - Washington D.C.

Florida

  • Univ of Florida Health Science Ctr / Pediatrics - Jacksonville
  • Univ of Miami (Pediatric) - Miami

Illinois

  • Chicago Children's Memorial Hosp - Chicago
  • Univ of Chicago Children's Hosp - Chicago

Louisiana

  • Tulane Univ / Charity Hosp of New Orleans - New Orleans
  • Tulane Med Ctr Hosp - New Orleans

Alabama

  • Univ of Alabama at Birmingham Schl of Med / Pediatrics - Birmingham

Colorado

  • Children's Hosp of Denver - Denver

Georgia

  • Emory Univ Hosp / Pediatrics - Atlanta

Trial Details

FieldValue
Enrollment Target 250 participants

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00000780

The ClinicalTrials.gov registry entry for NCT00000780 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00000780 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT00000780 about?

NCT00000780 is a clinical study titled "A "Pre-Enrollment" Protocol for HIV-Infected Adolescents". PRIMARY: To identify, characterize, and co-enroll HIV-infected adolescents into existing and future ACTG (or other NIH-sponsored) HIV treatment protocols through the systematic and recurrent assessment of eligibility. To assess the ability of adolescents enrolled in ACTG 220 to adhere to ACTG (or ot...

What is the current status of trial NCT00000780?

This trial is currently completed. The enrollment target is 250 participants.

What conditions does trial NCT00000780 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00000780?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000780 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.